BriaCell Therapeutics Corp.BCTXNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank93
3Y CAGR+42.5%
5Y CAGR+58.2%
Year-over-Year Change
Research and development spending
3Y CAGR
+42.5%/yr
vs +34.6%/yr prior
5Y CAGR
+58.2%/yr
Recent deceleration
Acceleration
+7.9pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
9.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $29.50M | -20.6% |
| 2024 | $37.14M | +80.3% |
| 2023 | $20.60M | +102.0% |
| 2022 | $10.20M | +295.6% |
| 2021 | $2.58M | -13.5% |
| 2020 | $2.98M | -39.7% |
| 2019 | $4.94M | +58.9% |
| 2018 | $3.11M | +46.4% |
| 2017 | $2.12M | +123.1% |
| 2016 | $952150.00 | - |